Long-term psychological and educational outcomes for survivors of neuroblastoma: A report from the Childhood Cancer Survivor Study

Cancer

Volumn 124, Issue 15, 2018, Pages 3220-3230

  Zheng, Daniel J ^a,b,c   Krull, Kevin R ^d   Chen, Yan ^e   Diller, Lisa ^f,g   Yasui, Yutaka ^d   Leisenring, Wendy ^h   Brouwers, Pim ⁱ   Howell, Rebecca ^j   Lai, Jin Shei ^k   Balsamo, Lyn ^a,l   Oeffinger, Kevin C ^m   Robison, Leslie L ^d   Armstrong, Gregory T ^d   Kadan Lottick, Nina S ^a,l  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c BOSTON MEDICAL CENTER   (United States)

^d ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^e UNIVERSITY OF ALBERTA   (Canada)

^f DANA FARBER CANCER INSTITUTE   (United States)

^g HARVARD MEDICAL SCHOOL   (United States)

^h USA   (United States)

ⁱ NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^j UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l YALE CANCER CENTER   (United States)

^m DUKE CANCER INSTITUTE   (United States)

more..

Author keywords

cancer survivorship; chronic health; educational outcomes; neuroblastoma; psychological outcomes

Indexed keywords

ALKYLATING AGENT; CARMUSTINE; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; CYCLOPHOSPHAMIDE; IFOSFAMIDE; LOMUSTINE; MELPHALAN; PLATINUM COMPLEX; PROCARBAZINE; RETINOIC ACID; THIOTEPA; VINCRISTINE;

ADOLESCENT; ANTISOCIAL BEHAVIOR; ANXIETY; ARTICLE; ATTENTION DEFICIT DISORDER; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVOR; CHILD; COHORT ANALYSIS; COLLEGE; CONTROLLED STUDY; DEPRESSION; EDUCATION; ENDOCRINE DISEASE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; INFANT; LUNG DISEASE; MAJOR CLINICAL STUDY; NEUROBLASTOMA; PEER GROUP; PERIPHERAL NEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PROBLEM BEHAVIOR; PSYCHOLOGICAL ASPECT; PSYCHOSOCIAL WITHDRAWAL; RETROSPECTIVE STUDY; SIBLING; SPECIAL EDUCATION; COMPLICATION; FEMALE; HEALTH STATUS; MALE; MENTAL STRESS; NEWBORN; PATHOLOGY; PRESCHOOL CHILD; PSYCHOLOGY; QUESTIONNAIRE; RISK FACTOR;

ADOLESCENT; CANCER SURVIVORS; CHILD; CHILD, PRESCHOOL; DEPRESSION; FEMALE; HEALTH STATUS; HUMANS; INFANT, NEWBORN; MALE; NEUROBLASTOMA; RISK FACTORS; SIBLINGS; STRESS, PSYCHOLOGICAL; SURVEYS AND QUESTIONNAIRES;

EID: 85050956849     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.31379     Document Type: Article

References (52)

1. Horner M, Ries L, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2006. Bethesda, MD: National Cancer Institute; 2009
2. Weinstein JL, Katzenstein HM, Cohn SL. Advances in the diagnosis and treatment of neuroblastoma. Oncologist. 2003;8:278-292
3. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202-2211
4. Laverdiere C, Cheung NKV, Kushner BH, et al. Long-term complications in survivors of advanced stage neuroblastoma. Pediatr Blood Cancer. 2005;45:324-332
5. Carpentieri S, Diller L. Neuropsychological resiliency after treatment for advanced stage neuroblastoma. Bone Marrow Transplant. 2005;35:1117-1122
6. Cohen L, Gordon J, Popovsky E, et al. Late effects in children treated with intensive multimodal therapy for high-risk neuroblastoma: high incidence of endocrine and growth problems. Bone Marrow Transplant. 2014;49:502-508
7. Laverdiere C, Liu Q, Yasui Y, et al. Long-term outcomes in survivors of neuroblastoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst. 2009;101:1131-1140
8. Goodman MT, Gurney J, Smith M, Olshan A. Sympathetic nervous system tumors. In: Ries LAG, Smith MA, Gurney JG, eds, et al. Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program 1975-1995. Bethesda, MD: National Cancer Institute; 1999:65-72
9. Pizzo PA, Poplack DG, Adamson PC, Blaney SM, Helman LJ. Principles and Practice of Pediatric Oncology. Lippincott Williams & Wilkins: Philadelphia, PA; 2006
10. Taylor HG, Alden J. Age-related differences in outcomes following childhood brain insults: an introduction and overview. J Int Neuropsychol Soc. 1997;3:555-567
11. Wallander JL, Varni JW. Effects of pediatric chronic physical disorders on child and family adjustment. J Child Psychol Psychiatry. 1998;39:29-46
12. Patenaude AF, Kupst MJ. Psychosocial functioning in pediatric cancer. Journal of Pediatr Psychol. 2005;30:9-27
13. Buizer AI, De Sonneville LM, Van Den Heuvel-Eibrink MM, Njiokiktjien C, Veerman AJ. Visuomotor control in survivors of childhood acute lymphoblastic leukemia treated with chemotherapy only. J Int Neuropsychol Soc. 2005;11:554-565
14. Buizer AI, de Sonneville LM, van den Heuvel–Eibrink MM, Veerman AJ. Chemotherapy and attentional dysfunction in survivors of childhood acute lymphoblastic leukemia: effect of treatment intensity. Pediatr Blood Cancer. 2005;45:281-290
15. Krull KR, Sabin ND, Reddick WE, et al. Neurocognitive function and CNS integrity in adult survivors of childhood Hodgkin lymphoma. J Clin Oncol. 2012;30:3618-3624
16. Robison LL, Armstrong GT, Boice JD, et al. The Childhood Cancer Survivor Study: a National Cancer Institute–supported resource for outcome and intervention research. J Clin Oncol. 2009;27:2308-2318
17. Leisenring WM, Mertens AC, Armstrong GT, et al. Pediatric cancer survivorship research: experience of the Childhood Cancer Survivor Study. J Clin Oncol. 2009;27:2319-2327
18. Gerhardt CA, Yopp JM, Leininger L, et al. Brief report: post-traumatic stress during emerging adulthood in survivors of pediatric cancer. J Pediatr Psychol. 2007;32:1018-1023
19. Robison LL, Mertens AC, Boice JD, et al. Study design and cohort characteristics of the Childhood Cancer Survivor Study: a multi-institutional collaborative project. Med Pediatr Oncol. 2002;38:229-239
20. Zill N. Behavior Problems Index Based on Parent Report. Bethesda, MD: Child Trends; 1990
21. Schultz KAP, Ness KK, Whitton J, et al. Behavioral and social outcomes in adolescent survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. J Clin Oncol. 2007;25:3649-3656
22. Lozoff B, Jimenez E, Hagen J, Mollen E, Wolf AW. Poorer behavioral and developmental outcome more than 10 years after treatment for iron deficiency in infancy. Pediatrics. 2000;105:e51
23. Kuczmarski RJ, Ogden CL, Guo SS, et al. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat 11. 2002;246:1-190
24. Ogden CL, Flegal KM. Changes in terminology for childhood overweight and obesity. Natl Health Stat Report. 2010;25:1-5
25. Diller L, Chow EJ, Gurney JG, et al. Chronic disease in the Childhood Cancer Survivor Study cohort: a review of published findings. J Clin Oncol. 2009;27:2339-2355
26. Oeffinger KC, Mertens AC, Sklar CA, et al. Chronic health conditions in adult survivors of childhood cancer. N Engl J Med. 2006;355:1572-1582
27. National Cancer Institute. Common Terminology Criteria for Adverse Events v4.03. Bethesda, MD: National Cancer Institute; 2016
28. Ness KK, Hudson MM, Jones KE, et al. Effect of temporal changes in therapeutic exposure on self-reported health status in childhood cancer survivors. Ann Int Med. 2017;166:89-98
29. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290:1583-1592
30. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics. 1986;42:121-130
31. Copeland DR, Dowell RE, Fletcher JM, et al. Neuropsychological effects of childhood cancer treatment. J Child Neurol. 1988;3:53-62
32. Hockenberry M, Krull K, Moore K, Gregurich MA, Casey ME, Kaemingk K. Longitudinal evaluation of fine motor skills in children with leukemia. J Pediatr Hematol Oncol. 2007;29:535-539
33. Kaemingk KL, Carey ME, Moore IM, Herzer M, Hutter JJ. Math weaknesses in survivors of acute lymphoblastic leukemia compared to healthy children. Child Neuropsychol. 2004;10:14-23
34. Gurney JG, Tersak JM, Ness KK, Landier W, Matthay KK, Schmidt ML. Hearing loss, quality of life, and academic problems in long-term neuroblastoma survivors: a report from the Children's Oncology Group. Pediatrics. 2007;120:e1229-e1236
35. Kadan-Lottick NS, Zeltzer LK, Liu Q, et al. Neurocognitive functioning in adult survivors of childhood non–central nervous system cancers. J Natl Cancer Inst. 2010;102:881-893
36. Vuotto SC, Krull KR, Li C, et al. Impact of chronic disease on emotional distress in adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. Cancer. 2017;123:521-528
37. Bugnicourt JM, Godefroy O, Chillon JM, Choukroun G, Massy ZA. Cognitive disorders and dementia in CKD: the neglected kidney-brain axis. J Am Soc Nephrol. 2013;24:353-363
38. Zammit AR, Katz MJ, Lai JY, Zimmerman ME, Bitzer M, Lipton RB. Association between renal function and cognitive ability domains in the Einstein aging study: a cross-sectional analysis. J Gerontol A Biol Sci Med Sci. 2014;70:764-770
39. Upton P, Lawford J, Eiser C. Parent-child agreement across child health-related quality of life instruments: a review of the literature. Qual Life Res. 2008;17:895-913
40. Zebrack BJ, Zevon MA, Turk N, et al. Psychological distress in long-term survivors of solid tumors diagnosed in childhood: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2007;49:47-51
41. Nathan PC, Ness KK, Greenberg ML, et al. Health-related quality of life in adult survivors of childhood Wilms tumor or neuroblastoma: a report from the Childhood Cancer Survivor Study. Pediatr Blood Cancer. 2007;49:704-715
42. Zeltzer LK, Lu Q, Leisenring W, et al. Psychosocial outcomes and health-related quality of life in adult childhood cancer survivors: a report from the Childhood Cancer Survivor Study. Cancer Epidemiol Biomarkers Prev. 2008;17:435-446
43. Bona K, Blonquist TM, Neuberg DS, Silverman LB, Wolfe J. Impact of socioeconomic status on timing of relapse and overall survival for children treated on Dana-Farber Cancer Institute ALL consortium protocols (2000-2010). Pediatr Blood Cancer. 2016;63:1012-1018
44. Petridou ET, Sergentanis T, Perlepe C, et al. Socioeconomic disparities in survival from childhood leukemia in the United States and globally: a meta-analysis. Ann Oncol. 2015;26:589-597
45. Pelletier W, Bona K. Assessment of financial burden as a standard of care in pediatric oncology. Pediatr Blood Cancer. 2015;62:S619-S631
46. Bona K, London WB, Guo D, Frank DA, Wolfe J. Trajectory of material hardship and income poverty in families of children undergoing chemotherapy: a prospective cohort study. Pediatr Blood Cancer. 2016;63:105-111
47. Stein KD, Syrjala KL, Andrykowski MA. Physical and psychological long-term and late effects of cancer. Cancer. 2008;112:2577-2592
48. Barrera M, Shaw AK, Speechley KN, Maunsell E, Pogany L. Educational and social late effects of childhood cancer and related clinical, personal, and familial characteristics. Cancer. 2005;104:1751-1760
49. Green DM, Nolan VG, Goodman PJ, et al: The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study. Pediatric Blood & Cancer. 2014;61:53-67
50. Pickard AS, Topfer LA, Feeny DH. A structured review of studies on health-related quality of life and economic evaluation in pediatric acute lymphoblastic leukemia. J Natl Cancer Inst Monogr. 2004;2004:102-125
51. Varni JW, Limbers CA, Burwinkle TM. Parent proxy-report of their children's health-related quality of life: an analysis of 13,878 parents' reliability and validity across age subgroups using the PedsQL™ 4.0 Generic Core Scales. Health Qual Life Outcomes. 2007;5:2
52. Pinto NR, Applebaum MA, Volchenboum SL, et al. Advances in risk classification and treatment strategies for neuroblastoma. J Clin Oncol. 2015;33:3008-3017